Therapeutic Drug Monitoring of Nevirapine in Resource‐Limited Settings

Abstract

The TLC assay was found to be sensitive, specific, and robust in the detection of subtherapeutic nevirapine concentrations in saliva specimens obtained from African HIV-infected adults. It is an attractive alternative to HPLC for therapeutic drug monitoring of nevirapine in resource-limited settings.

References

Page 1

	Year	Citations
A Coefficient of Agreement for Nominal Scales Jacob Cohen Educational and Psychological Measurement Natural Language ProcessingEngineeringLanguage CorpusInterobserver AgreementDistributional Semantics	1960	40.1K
Measuring nominal scale agreement among many raters. Joseph L. Fleiss Psychological Bulletin ReliabilitySurvey (Human Research)EngineeringGeneralizability TheoryInterobserver Agreement	1971	8.3K
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals Agnes I. Veldkamp, Gerrit Jan Weverling, Joep M. A. Lange, AIDS	2001	207
Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, Malawi Joep J. van Oosterhout, Neena Bodasing, Johnstone J. Kumwenda, Tropical Medicine & International Health	2005	148
Updated guideline to perform therapeutic drug monitoring for antiretroviral agents. C. J. L. la Porte, David Back, Terrence F. Blaschke, Therapeutic Drug MonitoringTreatment And PreventionPharmacologyAntiviral TherapyDrug Monitoring	2006	104
Low Nevirapine Plasma Concentrations Predict Virological Failure in an Unselected HIV-1-Infected Population T.E.M.S. de Vries-Sluijs, Jeanne P. Dieleman, Dennis Arts, Clinical Pharmacokinetics Human RetrovirusClinical EpidemiologyAntiviral TherapyVirologyChronic Viral Infection	2003	104
Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography R.M.F. Hollanders, E.W.J. van Ewijk-Beneken Kolmer, David M. Burger, Journal of Chromatography B Biomedical Sciences and Applications MedicineHuman RetrovirusBioanalysisAntiviral Drug DevelopmentAntiviral Therapy	2000	63
Nevirapine Plasma Concentrations are Still Detectable After More Than 2 Weeks in the Majority of Women Receiving Single-Dose Nevirapine Eva Muro, J. A. H. Droste, Hadewych ter Hofstede, JAIDS Journal of Acquired Immune Deficiency Syndromes	2005	61
Brief Report: Enzyme Inducers Reduce Elimination Half-Life After a Single Dose of Nevirapine in Healthy Women Rafa lla F. A L homme, Tim Dijkema, André van der Ven, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	36
Saliva as an Alternative Body Fluid for Therapeutic Drug Monitoring of the Nonnucleoside Reverse Transcription Inhibitor Nevirapine Rolf P.G. van Heeswijk, Agnes I. Veldkamp, Jan‐Willem Mulder, Therapeutic Drug Monitoring	2001	31

Page 1